Press Release
LingSense Bio Debuts in Silicon Valley With Advanced CGM & Wearable Dynamic Blood Pressure Technology
While the global digital health industry remains focused on specification-driven competition and fragmented use cases, LingSense Bio, a rising Chinese medtech innovator, chose Silicon Valley as the stage to present its answer.
At the “BEYOND SLEEP: THE STAREEP PREMIERE” global launch event, LingSense Bio, official medical health partner of smart sleep brand Stareep, made its international debut, introducing a comprehensive, closed-loop health management solution that integrates hardware, software, and AI services. This innovation aims to redefine healthcare standards for billions of chronic disease patients worldwide.
LingSense Bio’s wearable product lineup made a stunning debut
The LingSense Bio Ecosystem Ushers in an All in One AI Era of Seamless Monitoring
With the global chronic disease management market expanding rapidly into a trillion-dollar industry, Faris Li, Head of Product at LingSense Bio, delivered a keynote speech titled “Redefining Health Monitoring with Healthcare AI Wearables.” His assessment was direct: “Hardware alone cannot solve the challenges of chronic disease management. Without AI-driven intervention, health data is just a pile of numbers.”
Faris highlighted that while over 626 million people suffer from cardiovascular diseases and 830 million live with diabetes globally, continuous glucose monitoring (CGM) penetration among type 2 diabetes patients remains below 10%. Furthermore, dynamic blood pressure monitoring has long been constrained by traditional cuff-based devices. “Patients need unobtrusive, continuous, and precise monitoring, not fragmented occasional readings,” Faris emphasized. The future of medical-grade wearables, he noted, lies in two key trends: multi-parameter “All-in-One” integration and deep AI embedding from edge to platform.
To address these needs, LingSense Bio has developed a product matrix. Faris Li showcased two groundbreaking core hardware innovations:
Continuous Glucose Monitor (CGM): Boasting an industry-leading MARD (Mean Absolute Relative Difference) of under 8.0%, rivaling top-tier global brands.
Wearable dynamic Blood Pressure Monitor (dBP): The world’s first wearable dBP powered by Tonoarteriography (TAG) technology, developed by Professor Yuan-Ting Zhang’s team, delivering medical-grade continuous blood pressure tracking.
LingSense Bio also introduced LingWatch Pro, a smart watch with dynamic blood pressure monitoring; LingRing Nexus R1, a smart ring integrating non-invasive blood glucose trend monitoring, PPG, blood oxygen, temperature, and heart rate variability (HRV) monitoring; and LingCare SpringMini, a portable oxygen concentrator designed to provide stable oxygen supply at altitudes of up to 6,000 meters.
These devices function as specialized physiological sensors that stream data into the LingSense Chronic Disease Management Platform, forming a closed-loop ecosystem covering glucose, blood pressure, blood oxygen, and ECG.
Faris Li delivered a keynote speech titled “Redefining Health Monitoring with Healthcare AI Wearables.”
Professor Yuan-Ting Zhang: Three Decades of Cuffless Innovation Reach Industrial Standard Moment
At the event, Professor Yuan-Ting Zhang, a Fellow of the International Academy for Medical and Biological Engineering, delivered a presentation titled “AI-Empowered Tonoarteriography for Digital Cardiovascular Health.” With over 30 years of pioneering research in cuffless blood pressure monitoring, Academician Zhang shared clinical insights and engineering philosophies that underscore the team’s forward-looking approach to digital cardiovascular health.
Professor Zhang pointed out that traditional blood pressure monitoring fails to capture critical nocturnal data. Clinical follow-ups from the Dublin Hypertension Clinic show that nighttime hypertension is highly correlated with a 5-year risk of cardiovascular mortality, and increased blood pressure variability serves as an independent warning sign. “However, traditional cuff-based devices cannot frequently inflate while a patient is sleeping without disrupting their rest,” Professor Zhang noted, highlighting the necessity of cuffless wearable technology. The deep learning models developed by his team for systolic and diastolic measurements have already achieved Grade A performance under IEEE, AAMI, and BHS standards.
Professor Yuan-Ting Zhang delivered a presentation titled “AI-Empowered Tonoarteriography for Digital Cardiovascular Health.”
The “dBP” solution represents a new era of 24/7 health management. By fusing physiological sensing, intelligent algorithms, and continuous data analysis, it offers a natural, low-burden monitoring experience. “The dBP focuses on long-term health trends rather than isolated readings,” Professor Zhang explained. “By analyzing continuous data streams, the system can provide valuable clinical insights for diagnosing masked hypertension, nocturnal anomalies, and evaluating chronic disease risks.”
Notably, Daniel Franklin, an Assistant Professor in the Institute of Biomedical Engineering at the University of Toronto, traveled to Silicon Valley as a specially invited international guest for the event. He participated in a session themed “Technology & Healthy Sleep,” where he engaged in an in-depth academic dialogue with fellow attendees. Known for his work in bio-integrated electronics and soft-matter photonics, Franklin offered an independent, clinically informed perspective on the event’s most anticipated innovation, the wearable dynamic blood pressure (dBP) monitoring technology.
Daniel Franklin participated in a session themed “Technology & Healthy Sleep” and shared in-depth academic insights
Data from LingSense Bio’s wearable product matrix, including CGM readings, ambulatory blood pressure data, blood oxygen saturation, and ECG signals, will be synchronized in real time to the LingSense Chronic Disease Management Platform. Built on LingSense Bio’s self-developed, medical-grade AI large model, the platform analyzes continuous health data and identifies potential risk patterns. It further incorporates Dr. PAI (Personalized AI Doctor), the world’s first hypertension intelligent management platform that combines a wearable dynamic blood pressure monitoring device, an AI health assistant avatar, and a large language model, developed by the team led by Professor Zhang. Together, they deliver a closed-loop experience spanning AI-powered consultation, health assessment, blood pressure pattern recognition, and personalized health management recommendations.
In January 2026, the U.S. Food and Drug Administration (FDA) officially released the draft guidance titled “Cuffless Non-invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation,” marking a long-awaited standard for the industrialization of a technology nearly three decades in the making. Professor Zhang’s team has been deeply involved in the development of both the FDA draft guidance and the relevant IEEE standard; the IEEE standard led by his team has already been adopted by the FDA as a reference. “The world is embracing this standard, and LingSense is ready to be tested,” Professor Zhang said.
A China-Born Solution for Global Standards
As the Silicon Valley sun cast its glow over Stanford, LingSense Bio’s brand logo lit up across the giant screen. Without complicated regulatory language or excessive marketing rhetoric, LingSense had already delivered its message: connecting China’s precision with the world’s broader healthcare needs.
From CGM systems with an MARD below 8.0% to the medical-grade continuous wearable blood pressure monitor dBP, LingSense Bio is challenging a market long dominated by industry giants like Dexcom and Abbott. But for chronic disease patients around the world, the most meaningful takeaway from this launch may be what LingSense Bio President Zhifeng Peng put most simply: “Whether you live in a major city or a remote village, expert-level personal healthcare should not be a privilege.” This China-born solution, making its debut in Silicon Valley, is now accelerating onto the global stage.
Media Contact
Organization: LingSense Bio (Shenzhen) Technology Co., Ltd.
Contact Person: Ying Jixuan (Nancy)
Website: https://en.lingshee.com
Email:
yingjixuan@dreame.tech
City: Shanghai
Country:China
Release id:45276
The post LingSense Bio Debuts in Silicon Valley With Advanced CGM & Wearable Dynamic Blood Pressure Technology appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Arbitflow has expanded access to managed crypto trading through a platform built around professional traders and user-directed capital allocation. The service allows users to select traders, distribute funds across different strategies, and follow performance without managing every trade themselves. Arbitflow targets users who want market exposure but prefer not to monitor charts or execute trades throughout the day. Instead, selected professionals handle position management while users retain control over how capital is distributed.
Auckland, New Zealand, 16th Sep 2026 – Arbitflow allows users to allocate funds to individual professional traders rather than rely on a single trading model. Capital can also be allocated across several strategies, giving users more flexibility in structuring their managed exposure.
Each trader follows their own approach when managing positions through the platform. Users can review available trading histories and performance information before deciding where to allocate capital.
The model allows users to adjust how much capital each trader receives. This structure gives users the option to build a managed setup around several professionals instead of concentrating funds in one strategy. Arbitflow also keeps the starting requirement at $25. The entry level gives users access to professional crypto trading without requiring a large initial allocation.
Trader Records and Live Trading Support User Oversight
Arbitflow applies a screening process before traders can manage capital through the platform. Candidates complete identity verification, professional-history checks, and simulated skills testing before approval.
After traders join, the platform continues monitoring their performance and trading activity. These records become part of the information users can review when comparing available professionals.
Live Trading provides another layer of visibility by displaying trader performance, trading history, and most completed trades. Users can follow the activity without taking over the daily execution process themselves.
This setup separates user oversight from day-to-day trade management. Users decide which traders receive capital, while approved professionals remain responsible for managing positions under their selected strategies.
Spot Execution and AI Support Sit Behind the Service
Arbitflow conducts trading exclusively through spot markets and does not use leverage or margin. Traders work with allocated funds rather than borrowing capital to increase position sizes. The structure removes leverage-driven liquidation risk from the service, although normal cryptocurrency market risk remains. Digital asset prices can still decline, reducing the value of managed allocations.
Arbitflow also uses proprietary AI-supported analysis within its trading infrastructure. The technology processes market conditions, news, trader behavior, performance data, and potential risk factors. Professional traders use that information as part of their research and monitoring process. Final trading decisions remain with the professionals managing each strategy.
Arbitflow began market research and strategy development in 2023 before building its current AI infrastructure. The technology was developed around existing trading workflows rather than a fully automated execution model.
About Arbitflow
Arbitflow is an AI-supported managed crypto trading platform that connects users with professional traders through a spot-only trading model. The platform combines human-led trade execution with proprietary AI analysis, trader screening, performance monitoring, and Live Trading functionality. Users can allocate capital across multiple traders and strategies while retaining control over how their funds are distributed. For more details, visit https://arbitflow.net/.
Mail
support@arbitflow.net
ads@arbitflow.net
Telegram Support
Media Contact
Organization: ARBITFLOW SOLUTIONS LIMITED
Contact Person: Lucas Horak
Website: https://arbitflow.net/
Email:
support@arbitflow.net
Contact Number: +15054983759
City: Auckland
Country: New Zealand
Release id: 49089
The post Arbitflow Expands Professional Crypto Trading Access Through Managed Strategies appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
A Dublin childhood, decades of hidden addiction, and a hard-won recovery: a new memoir traces one man’s journey from a Dublin tenement to sobriety on Long Island
NEW YORK—September 16, 2026—Apateon Press today announced the publication of The Irish Telegram Boy: A Memoir by Thomas A. McCluskey. The book tells the story of a boy raised to believe he was, in his family’s words, a “good-for-nothing,” and the decades-long journey that led him to prove otherwise.
Born into poverty in a Dublin tenement in 1944, McCluskey grew up in a large, quarrelsome Irish Catholic household marked by an absent father, a mother unable to show him warmth, and the daily indignities of poverty. At sixteen, he emigrated alone to New York, hoping for a fresh start. Instead, the wounds of his childhood followed him through difficult jobs, a failed first marriage, a second marriage and fatherhood, and years of escalating alcoholism. The memoir opens at his lowest point, lying paralyzed at the bottom of his basement stairs after a night of drinking, his body failing from decades of heavy smoking and drinking, and a near-fatal accident the next day that finally convinced him something had to change.
“I spent most of my life believing I was the family screwup and trying to prove I wasn’t,” said McCluskey. “Writing this book meant going back into rooms I had spent decades trying to forget, like the tenement in Dublin and the basement on Long Island, but then, on to the church basements where I finally got sober. I want readers who are still fighting their own version of that fight to know it is possible to come out the other side.”
The Irish Telegram Boy moves from Dublin tenements to the streets of Queens, from a first marriage that collapses under the weight of drinking and financial strain to a second marriage and family life that mask a worsening addiction. Through therapy, Alcoholics Anonymous, and a hard-won faith, McCluskey confronts his past, breaks a cycle of generational pain, and finds what he calls his own voice. Told in plainspoken, scene-driven prose, the book sits in the tradition of the Irish-immigrant addiction-and-recovery memoir, with McCluskey’s sobriety and self-understanding as its destination.
“The Irish Telegram Boy is an unsparing, deeply human account of what it takes to break a cycle of addiction that runs through generations,” said Hugh Taylor, President of Apateon Press. “Thomas doesn’t spare himself in these pages, and that honesty is exactly what makes his recovery so believable and so earned.”
The Irish Telegram Boy: A Memoir (ISBN 979-8-9973388-2-4) is now available on Amazon.com.
About Thomas A. McCluskey
Thomas A. McCluskey was born in Dublin, Ireland, in 1944 and emigrated to New York at the age of sixteen. He built a life and raised a family on Long Island while struggling for years with alcoholism before achieving lasting sobriety through therapy, Alcoholics Anonymous, and faith. The Irish Telegram Boy is his first book.
About Apateon Press
Apateon Press is an independent publishing company dedicated to bringing distinctive voices and compelling ideas to readers. The company publishes books designed to engage readers, challenge assumptions, and contribute to meaningful conversations.
For more information, visit https://apateonpress.com
Media Contact
Organization: Apateon Press
Contact Person: Hugh Taylor
Website: https://apateonpress.com
Email: Send Email
Country: United States
Release id: 49181
The post Apateon Press Publishes The Irish Telegram Boy by Thomas A. McCluskey appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
MEXC July–August Security Report: 38.66M USDT in Risk Funds Intercepted, Futures Insurance Fund Hits 792M USDT
Mutsamudu, Comoros, September 16th, 2026, Chainwire
MEXC, a pioneer in 0-fee digital asset trading, has released its July–August 2026 security report. The report shows that MEXC successfully intercepted all 215 reports involving risk-related funds during the period, covering approximately 38.66 million USDT. The total balance of the Futures Insurance Fund rose to 792 million USDT. Meanwhile, the reserve ratios for BTC, ETH, USDT, and USDC all remained above 100%.
In July and August 2026, the crypto industry recorded 184 security incidents, with reported losses totaling approximately $535 million. Phishing and fraud incidents, together with endpoint and supply-chain security incidents, accounted for approximately 48% of the total. At the same time, a growing number of attackers are using AI to auto-generate phishing content and help write malware, increasing the efficiency of their attacks. As attack methods become more diverse, promptly identifying and intercepting risk-related funds and strengthening cross-platform investigation have become increasingly important to reducing user losses.
All 215 Reports of Risk-Related Funds Successfully Intercepted, Covering 38.66 million USDT
In July and August, MEXC assisted with 215 reports involving externally stolen or fraud-related funds flowing into the platform. All 215 cases were successfully intercepted, covering 38,655,490 USDT. Of these cases, 42 involved assistances with judicial freezes. Compared with the previous reporting period, the number of successfully intercepted cases increased by approximately 2,971%, while the value of intercepted funds increased by approximately 12,646%.
In tracking and handling risk-related funds, MEXC shared suspicious addresses with major industry participants, assisted in identifying fund flows, and supported verification and freezing procedures under established joint-investigation and law-enforcement cooperation procedures.
Over 20,000 Risk-Related Accounts Identified and Restricted, With More Than 600,000 USDT in Misdirected Assets Returned
In account risk identification, MEXC identified and restricted 20,752 accounts associated with risk-related activities during the period, an increase of 118.03% from the previous reporting period. The platform identified 5,288 risk groups, up 20.35%. By region of origin, these groups were concentrated primarily in the Commonwealth of Independent States (1,803), Nigeria (1,099), and Indonesia (976).
For user asset recovery, MEXC manually processed 818 applications for the return of misdirected assets, returning the equivalent of 602,225 USDT, an increase of 75.31% from the previous reporting period.
Futures Insurance Fund Reaches 792 million USDT, Strengthening Protection Against Negative Balance Risk
As of September 1, 2026, the total balance of the MEXC Futures Insurance Fund reached 791,696,422 USDT, an increase of 5.44% from the previous reporting period.
The Futures Insurance Fund covers negative balances that may arise during liquidation, providing a risk buffer during extreme market conditions and helping reduce the likelihood of auto-deleveraging (ADL). When a liquidated position is closed at a price better than the bankruptcy price, the remaining funds are credited to the fund. Users can view the real-time balance on the MEXC Proof of Trust page.
Reserve Ratios for Four Major Assets Remain Above 100%, With BTC at Approximately 288%
According to the proof of reserves disclosed for this period, MEXC maintained reserve ratios above 100% for four major assets, as follows:
- Bitcoin (BTC): reserve ratio of approximately 288%, with total wallet assets of 12,312.75 BTC against 4,282.20 BTC in user assets;
- Ethereum (ETH): reserve ratio of approximately 113%, with total wallet assets of 66,227.79 ETH;
- USDT: reserve ratio of approximately 115%, with total wallet assets of approximately 1.940 billion USDT;
- USDC: reserve ratio of approximately 114%, with total wallet assets of approximately 194.85 million USDC.
The on-chain addresses corresponding to these reserve assets have been disclosed, allowing users to verify through the Merkle Tree whether their individual account balances were included in this proof of reserves.
As an additional layer of user asset protection, the MEXC Guardian Fund maintains a dual-reserve structure of USDT and BTC: USDT provides immediate liquidity support, while BTC serves as a long-term reserve asset across market cycles. MEXC plans to expand the fund from $100 million to $500 million, continuing to strengthen user asset protection. The relevant holding addresses are listed below:
Guardian Fund Wallet Addresses:
- USDT: 0x469AfE803C54A36674C55231489Cf4b61da8c1bC
- BTC: 1MDVjZdX8QD212pT8Z8EMP7DuFQHKqN3mx
MEXC CEO Vugar Usi said, “Trust is the true reserve currency of this industry. Protecting user assets means moving decisively the moment risk emerges, while giving users something they can verify for themselves, not just our word for it. We will continue to strengthen our ability to identify and intercept risk-related funds, deepen cooperation across platforms and with law enforcement, and help affected users recover their losses wherever possible. Our bi-monthly security reports are part of that commitment, allowing our security performance to be measured and tracked over time.”
About MEXC
Founded in 2018, MEXC is a leading global multi-asset trading platform built as your 0-fee gateway to infinite opportunities. Serving users across 170+ markets, MEXC provides simple and efficient access to crypto, stocks, tokenized assets, derivatives, and a growing range of TradFi-linked opportunities through one account and one gateway.
With 0 trading fees, deep liquidity, broad asset coverage, and a high-performance trading experience, MEXC is designed for retail users who want to discover earlier, act faster, and trade with fewer barriers. As crypto and traditional finance continue to converge, MEXC is committed to making global opportunities more accessible, helping users trade freely and MEXCmize every opportunity.
MEXC Official Website｜ X ｜ Telegram ｜How to Sign Up on MEXC
Contact
MEXC PR team
media@mexc.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Arbitflow Expands Professional Crypto Trading Access Through Managed Strategies
Apateon Press Publishes The Irish Telegram Boy by Thomas A. McCluskey
MEXC July–August Security Report: 38.66M USDT in Risk Funds Intercepted, Futures Insurance Fund Hits 792M USDT
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release1 week ago
Net Boardroom Launches Global Media Monitoring Platform with Multilingual Coverage and Alerts
-
Press Release4 days ago
CGTN: Embarking on third ‘golden decade’: How BRICS pools development strength for high-quality cooperation
-
Press Release1 week ago
The “Everlasting Battery” Inside Your Joints:UConn Professor’s Self-Powered Healing Material just Got Acquired
-
Press Release5 days ago
Shute Family Foundation Aims to Surpass 200k Raised for Tunnel to Towers at 6th Annual 9-11 Golf Tournament
-
Press Release7 days ago
Lily and Lime Offers Tips for Including Beloved Pets in Wedding Photography Without Disrupting the Celebration
-
Press Release4 days ago
Ronel Lamour Junior launches a self-check for South Florida homeowners before the next AC breakdown
-
Press Release5 days ago
Guggenheim Expands SEA Operations with Strategic Focus on Indonesia Led by Prof. Wong Woon Thiam
-
Press Release4 days ago
Quebec Brokerage Qubit Insurance Announces New Data on Coverage Shortfalls as Rebuilding Costs Rise